Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Observational Study of Iron Overload in Stem Cell Transplantation
This clinical trial update notes the completion of an observational study on iron overload in stem cell transplantation involving patients w…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia [Phase 1]
Phase 1 trial evaluating imatinib mesylate in combination with daunorubicin and cytarabine for relapsed acute myeloid leukemia. The study ha…
-
CLINICAL_TRIALS research · 2013-02-15Clinical Trial Update: Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical trial update evaluating Everolimus (RAD001) in elderly patients with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Stem Cell Transplantation for Hematological Malignancies [Phase 2, Phase 3]
This clinical trial update reports termination of a Phase 2/Phase 3 study evaluating stem cell transplantation for hematologic malignancies.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia [Phase 2]
Phase II open-label study of high-dose cytarabine combined with clofarabine in adults with refractory or relapsed acute myeloid leukemia or …
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating alvocidib with cytarabine and mitoxantrone in newly diagnosed acute myeloid leukemia has completed. Results were po…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: XK469R in Treating Patients With Refractory Hematologic Cancer [Phase 1]
Phase 1 trial update reporting initial safety and tolerability findings for XK469R in patients with refractory hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
NCI-sponsored Phase 1 clinical trial update of 6-Hydroxymethylacylfulvene (Irofulven) in patients with refractory acute myeloid leukemia, ac…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [Phase 1]
This clinical trial update summarizes a Phase 1 study of Imatinib Mesylate in patients with advanced cancer and liver dysfunction, which has…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Collection and Banking of Leukemia Cells MDS/AML [NA]
A completed clinical trial focusing on the collection and banking of leukemia cells in patients with myelodysplastic syndrome and acute myel…
-
CLINICAL_TRIALS research · 2013-02-07Clinical Trial Update: Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia
This document provides an update on a clinical trial evaluating conventional and experimental chemotherapy with allogeneic transplantation i…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 1, Phase 2]
This update reports on a Phase 1/2 clinical trial evaluating the combination of bortezomib, daunorubicin, and cytarabine in older patients w…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 trial data on tipifarnib in relapsed or refractory acute myeloid leukemia have been reported with the study status marked as complet…
-
FDA approval · 2013-02-04FDA Approved: DOXORUBICIN HYDROCHLORIDE — Original Application (BluePoint Laboratories)
FDA approved a generic doxorubicin hydrochloride product under Original Application for BluePoint Laboratories (ANDA 203263). This marks app…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 study of augmerosen with fludarabine and cytarabine in patients with refractory or relapsed acute myeloid leukemia or acute lymphobl…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies [Phase 1]
Phase 1 trial evaluating the combination of triapine (3-AP) with high-dose cytarabine in adults with advanced hematologic malignancies has c…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial of idarubicin and cytarabine with or without bevacizumab for newly diagnosed acute myeloid leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Cilengitide in Treating Patients With Acute Myeloid Leukemia [Phase 2]
A Phase 2 trial of cilengitide for acute myeloid leukemia was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial update (completed) of PS-341 (bortezomib) in patients with refractory or relapsed acute myeloid leukemia, acute lymph…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 study evaluating a rebeccamycin analog in adults with relapsed or refractory acute myeloid leukemia, myelodysplastic syndromes, acut…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase [Phase 2]
A Phase 2 trial evaluating CCI-779 (temsirolimus) in adults with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia [Phase 1]
Phase 1 study of BMS-214662 in patients with various leukemias and myelodysplastic syndromes has completed enrollment; the document lists th…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy [Phase 1, Phase 2]
This clinical trial update reports on a completed Phase 1/2 study of liposomal daunorubicin combined with SU5416 for hematologic cancers tha…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML) [Phase 1]
A Phase 1 trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of oral AT-406 in combination with daunorubicin …